Sumitomo Pharma America discloses data leak, possibly related to Cencora incident | Console and Associates, PC

On May 24, 2024, Sumitomo Pharma America, Inc. filed a data breach report with the Texas Attorney General after discovering that confidential information provided to the company was exposed to unauthorized access. In this report, Sumitomo explains that the incident resulted in an unauthorized party being able to access consumers’ confidential information, including their names, dates of birth, and medical information. However, it is possible that the data breach at Sumitomo is related to an incident at Cencora, a company that provides business services to pharmaceutical companies, as several pharmaceutical companies reported data breaches on the same day. Regardless, notification letters of the data breach will soon be sent to all individuals whose information was affected by the recent data security incident.

If you have received a data breach notification from Sumitomo Pharma America, Inc., it is important that you understand the risks involved and what you can do about them. A data breach lawyer can help you learn more about how to protect yourself from fraud or identity theft and discuss your legal options following the Sumitomo Pharma America data breach. For more information, see our recent article on this topic. Here.

What caused the data breach at Sumitomo Pharma America?

The data breach at Sumitomo Pharma America was only recently disclosed and more information is expected in the near future. Unfortunately, Sumitomo’s filing with the Texas Attorney General contains limited information about what led to the data breach. According to this source, information provided to Sumitomo Pharma America by consumers was exposed to unauthorized access. However, this does not necessarily mean that Sumitomo Pharma America’s computer network was hacked, as the incident could have been the result of data theft by a third party.

For example, Cencora, a services company that supports patient assistance programs, recently filed several data breach reports on behalf of pharmaceutical companies. It is possible that the data breach at Sumitomo Pharma America is related to the Cencora incident, but this has not been confirmed by either company.

After learning that sensitive consumer data was accessible to unauthorized parties, Sumitomo Pharma America reviewed the compromised files to determine what information was leaked and which consumers were affected. While the compromised information varies by individual, it may include your name, date of birth, and medical information.

On May 24, 2024, Sumitomo Pharma America reported the incident to the Texas Attorney General. Typically, companies send letters to victims of a data breach at this time; however, the timeline for Sumitomo Pharma America’s data breach may be different. Regardless, these letters should provide victims with a list of the information belonging to them that was compromised.

More information about Sumitomo Pharma America, Inc.

Sumitomo Pharma America, Inc. is a pharmaceutical company based in Marlborough, Massachusetts. Sumitomo Pharma America’s parent company, Sumitomo Pharma Co., Ltd., was founded in 1897. The company focuses on developing medicines for patients with conditions in the areas of psychiatry and neurology, oncology, urology, women’s health, rare diseases, and cell and gene therapies. Sumitomo Pharma America employs more than 48 people and generates annual sales of approximately $37 million.